Information intended for UK healthcare professionals only.  This promotional video has been funded by Sandoz Ltd and developed in conjunction with Guidelines. See bottom of the page for full disclaimer.

View prescribing information

In this video Dr Andrew Dickman (Consultant Pharmacist – Palliative care; Liverpool University Hospitals NHS Foundation Trust) summarises the main messages covered in the live webinar ’Targeting the cause of opioid-induced constipation with PAMORAs’, broadcast on 9 December 2020.

Targeting the cause of opioid-induced constipation with PAMORAs

Other videos in the series: 

Opioid-induced constipation: optimal management and the role of PAMORA drugs

Diagnosis and management of opioid-induced constipation

Adverse events should be reported. Reporting forms and Information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Sandoz Ltd, uk.patientsafety@novartis.com or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com. If you have a question about the product, please contact medical information on 01276 698 101 or by email at Sandozgb@EU.propharmagroup.com

This promotional video has been funded by Sandoz Ltd and developed in conjunction with Guidelines.  Sandoz Ltd has reviewed the scope of the video, chosen and commissioned the speaker, and approved all materials related to the video. Sandoz Ltd has paid the speaker an honorarium. The views and opinions of the speaker are not necessarily those of Guidelines, its publisher, advisers, or advertisers. No part of this video may be reproduced in any form without the permission of the publisher.

141580
Date of preparation: September 2021